Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain- mediated transcriptional activation

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6611-6618

  Harada, Shizuko ^a   Kieff, Elliott ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; TRANSCRIPTION REGULATION; VIRUS CELL TRANSFORMATION; VIRUS TRANSCRIPTION;

EID: 0030873493     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6611-6618.1997     Document Type: Article

References (61)

1. Abbot, S. D., M. Rowe, K. Cadwallader, A. Ricksten, J. Gordon, F. Wang, L. Rymo, and A. B. Rickinson, 1990. Epsiein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. J. Virol. 64:2126-2134.
2. Alfieri, C., M. Birkenbach, and E. Kieff, 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608.
3. Allan, G. J., G. J. Inman, B. D. Parker, D. T. Rowe, and P. J. Farrell. 1992. Cell growth effects of Epstein-Barr virus leader protein. J. Gen. Virol. 73: 1547-1551.
4. Aster, J., E. Robertson, R. Husserjian, J. Turner, E. Kieff, and J. Sklar. Oncogcnic forms of Notch 1 lacking either the primary binding site for RBPJk or nuclear localization sequences retain the ability to associate with RBPJk and activate transcription. J. Biol. Chem., in press.
5. Cisck, L. J., and J. L. Corden. 1989. Phosphorylation of RNA polymcrasc by the murine homologue of the cell cycle control protein cdc2. Nature 339: 679-684.
6. Cohen, J. I., and E. Kieff. 1991. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator. J. Virol. 65:5880-5885.
7. Cohen, J. I., F. Wang, and E. Kieff. 1991. Epstein-Barr virus nuclear protein-2 mutations define essential domains for transformation and transactivation. J. Virol. 65:2545-2554.
8. Cohen, J. I. 1992. A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2. Proc. Natl. Acad. Sci. USA 89:8030-8034.
9. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9528-9562.
10. Dash, A. B., F. C. Orrico, and S. vanNess. 1996. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev. 10:1858-1869.
11. Dillner, J., B. Kallin, and H. Alexander. 1986. An EBV determined nuclear antigen (EBNA5) partly encoded by the transformation associated Bam-WYG region of EBV-DNA: preferential expression in lymphoblastoid cell lincs. Proc. Natl. Acad. Sci. USA 83:6641-6645.
12. Ellisen, L. W., J. Bird, D. C. West, A. L. Soreng, T. C. Reynolds, S. D. Smith, and J. Sklar. 1991. Tun-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-661.
13. Finke, J., M. Rowe, B. Kallin, I. Ernberg, A. Rosén, J. Dillner, and G. Klein. 1987. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61:3870-3878.
14. Fortini, M. E., and S. Artavanis-Tsakonas. 1994. The Suppressor of Hairless protein participates in Notch receptor signaling. Cell 79:273-282.
15. Goodbourn, S. 1995. Notch takes a short cut. Nature 377:288-289.
16. K recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7568-7572.
17. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393-397.
18. K. Science 265:92-95.
19. Hennessy, K., and E. Kieff. 1985. A second nuclear protein is encoded by Epstein-Barr virus in latent infection. Science 227:1238-1240.
20. Inman, G. J., and P. J. Farrell. 1995. Epstein-Barr virus EBNA-LP and transcriptional regulation properties of pRh, pl07 and p53 in transfection assays. J. Gen. Virol. 76:2141-2149.
21. Jin, X., and S. Speck. 1992, Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependcnt activity of an enhancer located upstream of the viral BamHI C promoter. J. Virol. 66: 2846-2852.
22. K and PU.1. J. Virol. 69:253-262.
23. K in Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70:4179-4183.
24. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology. Lippincott-Raven, Philadelphia, Pa.
25. Kitay, M., and D. Rowe. 1996. Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins. Virology 220:91-99.
26. Kitay, M., and D. Rowe. 1996. Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP. J. Virol. 70:7885-7893.
27. Laux, G., L. Adam, J. Strobl, and F. Moreau-Gachelin. 1994. The Spi-1/PU.l and Spi-B ets family transcription factors and the recombination signal binding protein RBPJk interact with an Epstein-Barr virus nuclear protein 2 responsive cis-element. EMBO J. 13:5624-5632.
28. Le Roux, A., B. Kerdilles, D. Walls, J. Dedieu, and M. Perricaudet. 1994. The Epstein-Barr virus determined nuclear antigens EBNA-3A, EBNA-3B, EBNA-3C repress EBNA-2 mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205:596-602.
29. Lillie, J., and M. Green. 1989. Transcriptional activation by the adenovirus Ela protein. Nature 338:39-44.
30. Ling, P. D., J, Ryon, and S. D. Hayward, 1993. EBNA-2 of herpesvirus Papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67:2990-3003.
31. Ling, P, D., D. R. Rawlins, and S. D. Hayward. 1993. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad. Sci. USA 90:9237-9241.
32. Littlewood, T., D. Hancock, P. Danielian, M. Parker, and G. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
33. Manniek, J. B., J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kieff. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826-6837.
34. Mannick, J. B., X. Tong, A. Hennes, and E. Kieff. 1995. The Epstein-Barr virus nuclear antigen leader protein association with hsp72/hsc73. J. Virol. 69:8169-8172.
35. Marshall, D., and C, Sample. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
36. 2, repeat domain. J. Virol. 71:6619-6628.
37. Pear, W. S., J. C. Aster, M. L. Scott, R. P. Hasserjian, B. Soffer, J. Sklar, and D. Baltimore. 1996. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183:2283-2291.
38. Petti, L., C. Sample, and E. Kieff. 1990. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear protein. Virology 176:563-574.
39. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology. Lippincott-Raven, Philadelphia, Pa.
40. Robertson, E. S., S. Grossman, E. Johannsen, C. Miller., J. Lin, B. Tomkinson, and E. Kieff. 1995. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA binding protein J κ. J. Virol. 69:3108-3116.
41. Robertson, E. S., J. Lin, and E. Kieff. 1996. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJκ. J. Virol. 70:3068-3074.
42. 40a.Robertson, E. S., et al. Unpublished data.
43. Sadowski, I., J, Ma., S. Triezenberg, and M. Ptashne. 1988. Gal4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564.
44. Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff. 1986. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc. Natl. Acad. Sci. USA 83:5096-5100.
45. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321-3328.
46. Sjoblom, A., A. Jansson, W. Yang, S. Lain, T. Nilsson, and L. Rymo. 1995. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transcription of the EBV latent membrane protein 1 promoter. J. Gen. Virol. 76:2679-2692.
47. Szekely, L., G. Selivanova, K. P. Magnusson, G. Kline, and K. G. Wiman. 1993. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 90:5455-5459.
48. Szekely, L., K. Pokrovskaja, W.-Q. Jiang., H. de The, N. Ringertz, and G. Klein. 1996. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol. 70:2562-2568.
49. Tong, X., F. Wang, C. Thut, and E. Kieff. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TBP. J. Virol. 69:585-588.
50. Tong, X., R. Drapkin, D. Reinberg, and E. Kieff. 1995. The p62 and p80 subunits mediate TFIIH interaction with the Epstein-Barr virus protein 2. Proc. Natl. Acad. Sci. USA 92:3259-3263.
51. Tong, X., R. Drapkin, R. Yalamanchili, G. Mosialos, and E. Kieff, 1995. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol. 15:4735-4744.
52. Tsang, S., F. Wang, and E. Kieff. 1991. Delineation of the cis-acting element mediating EBNA2 transactivation of latent infection membrane protein expression. J. Virol. 65:6765-0771.
53. Van Santen, V., A. Cheung, M. Hummel, and E. Kieff. 1983. RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected growthtransformed cells. J. Virol. 46:424-433.
54. Wang, F., L. Petti, D. Braun, S. Seung, and E. Kieff. 1987. A bicistronk Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J. Virol. 61:945-954.
55. Wang, F., C. Gregory, M. Rowe, A. Rickinson, D. Wang, M. Birkenbach, H. Kikutani, T. Kishimoto, and E. Kieff. 1987. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 84:3452-3456.
56. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes; EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
57. Wang, F., S.-F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff, 1990. Epstein-Barr virus nuclear antigen 2 transactivates the latent membrane protein LMP1. J. Virol. 64:3407-3416.
58. Yalamanchili, R., X. Tong, S. R. Grossman, E. Johannsen, G. Mosialos, and E. Kieff. 1994. Genetic and biochemical evidence that EBNA 2 interaction with a 63 kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology 204:634-641.
59. Yalamanchili, R., S. Harada, and E. Kieff. 1996. The N-terminal half of EBNA-2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation. J. Virol. 70:2468-2473.
60. Zimber-Strobl, U., E. Kremmer, F. Grasser, G. Marsehall, G. Lauz, and G. W. Bornkamm. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12:167-175.
61. Zimber-Strobl, U., L. J. Strobl, C. Meitinger, R. Hinrichs, T. Sakai, T. Furukawa, T. Honjo, and G. W. Bornkamm. 1994. The Epstein-Barr virus nuclear antigen 2 exerts its function through interaction with recombination signal binding protein RBP-Jκ, the homologue of Drosophila suppressor of hairless. EMBO J. 13:4973-4982.